Use of the MyProstateScore (MPS) Test to Rule Out Clinically-Significant Cancer: Validation of a Straightforward Clinical Testing Approach.

Jeffrey J. Tosoian,Bruce J. Trock,Todd M. Morgan,Simpa S. Salami,Scott A. Tomlins,Daniel E. Spratt,Javed Siddiqui,Lakshmi P. Kunju,Rachel Botbyl,Zoey Chopra,Balaji Pandian,Nicholas W. Eyrich,Gary Longton,Yingye Zheng,Ganesh S. Palapattu,John T. Wei,Yashar S. Niknafs,Arul M. Chinnaiyan

Use of the MyProstateScore (MPS) Test to Rule Out Clinically-Significant Cancer: Validation of a Straightforward Clinical Testing Approach.

2020

Jeffrey J. Tosoian
Bruce J. Trock
Todd M. Morgan
Simpa S. Salami
Scott A. Tomlins
Daniel E. Spratt
Javed Siddiqui
Lakshmi P. Kunju
Rachel Botbyl
Zoey Chopra
Balaji Pandian
Nicholas W. Eyrich
Gary Longton
Yingye Zheng
Ganesh S. Palapattu
John T. Wei
Yashar S. Niknafs
Arul M. Chinnaiyan

Purpose:The MyProstateScore (MPS) test was validated for improved detection of clinically-significant (Grade Group [GG] ≥2) prostate cancer relative to PSA-based risk calculators. We sought to vali...

Keywords:

Medicine
Prostate cancer
Internal medicine
Biomarker (medicine)
Biopsy
Prostate-specific antigen
Oncology
Cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations